KRT19 and cancer: The present investigation is an extension of our initial work [11], including now as novel findings (a) the proof that full-length CK19 is released by cancer cells, (b) detailed clinical data on the cancer patients, and (c) most important, clinical follow-up information including multivariate analysis.